Abstract
Using polymerase chain reaction (PCR)-based sequence-specific primers, the killer immunoglobulin-like receptor (KIR) genotypes of 35 patients with natural killer (NK)-type lymphoproliferative disease of granular lymphocytes and of 50 normal subjects were investigated to evaluate whether genes coding for activating KIRs were more frequently detected in patients with NK-lymphoproliferative disease of granular lymphocytes (LDGL). Genotype frequency indicated that the most frequently found gene content was eight genes in controls and 14 in patients (P<0.05). The KIR genotype analysis revealed that patient and, surprisingly, control KIR genotypes preferentially consisted of type B haplotypes characterized by the presence of multiple-activating KIRs. Evidence was also provided that the same KIR genotype was shared by a variable number of patients. Interestingly, the recurrent genotypes observed in the patient group were not found in controls. Concerning inhibitory genes, KIR2DL5a and 2DL5b were more frequently detected in patients than in controls (P<0.01), likely representing a discrete feature of the genetic repertoire of the patients. KIR gene repertoire analysis in patients suggests that the susceptibility to NK-LDGL might be related to the presence of activating KIR genes and supports the concept that these receptors may be involved in the priming of granular lymphocytes (GL) proliferation. Population analysis might disclose a genetic background predisposing to this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran Jr TP . The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997; 89: 256–260.
Loughran Jr TP . Clonal diseases of large granular lymphocytes. Blood 1993; 82: 1–14.
Greer JP, Kinney MC, Loughran Jr TP . T cell and NK cell lymphoproliferative disorders. Hematology Am Soc Hematol Educ Program 2001, 259–281.
Zambello R, Falco M, Della Chiesa M, Trentin L, Carollo D, Castriconi R et al. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes. Blood 2003; 102: 1797–1805.
Epling-Burnette PK, Painter JS, Chaurasia P, Bai F, Wei S, Djeu JY et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 2004; 103: 3431–3439.
Pascal V, Schleinitz N, Brunet C, Ravet S, Bonnet E, Lafarge X et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur J Immunol 2004; 34: 2930–2940.
Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 2002; 168: 2307–2315.
Middleton D, Williams F, Halfpenny IA . KIR genes. Transplant Immunol 2005; 14: 135–142.
Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA . Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002; 100: 1935–1947.
Wende H, Colonna M, Ziegler A, Volz A . Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm Genome 1999; 10: 154–160.
Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B . Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002; 169: 5118–5129.
Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753–763.
Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'andrea A et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7: 739–751.
Denis L, Sivula J, Gourraud PA, Kerdudou N, Chout R, Ricard C et al. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 2005; 66: 267–276.
Hsu KC, Chida S, Geraghty DE, Dupont B . The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002; 190: 40–52.
Niokou D, Spyropoulou-Vlachou M, Darlamitsou A, Stavropoulos-Giokas C . Distribution of killer cell immunoglobulin-like receptors in the Greek population. Hum Immunol 2003; 64: 1167–1176.
Toneva M, Lepage V, Lafay G, Dulphy N, Busson M, Lester S et al. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 2001; 57: 358–362.
Maxwell LD, Ross OA, Curran MD, Rea IM, Middleton D . Investigation of KIR diversity in immunosenescence and longevity within the Irish population. Exp Gerontol 2004; 39: 1223–1232.
Becker S, Tonn T, Fussel T, Uhrberg M, Bogdanow M, Seifried E et al. Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. Hum Immunol 2003; 64: 183–193.
Parham P . Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response. Immunol Lett 2004; 92: 11–13.
Jiang K, Zhu FM, Lv QF, Yan LX . Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. Tissue Antigens 2005; 65: 556–563.
Semenzato G, Pandolfi F, Chisesi T, De Rossi G, Pizzolo G, Zambello R et al. The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 1987; 60: 2971–2978.
Zambello R, Semenzato G . Large granular lymphocytosis. Haematologica 1998; 83: 936–942.
Lamy T, Loughran Jr TP . Current concepts: large granular lymphocyte leukemia. Blood Rev 1999; 13: 230–240.
Zambello R, Loughran Jr TP, Trentin L, Pontisso P, Battistella L, Raimondi R et al. Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes. Leukemia 1995; 9: 1207–1211.
Sun JY, Gaidulis L, Miller MM, Goto RM, Rodriguez R, Forman SJ et al. Development of a multiplex PCR-SSP method for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 2004; 64: 462–468.
Vilches C, Gardiner CM, Parham P . Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immunol 2000; 165: 6416–6421.
Nearman ZP, Wlodarski M, Jankowska AM, Howe E, Narvaez Y, Ball E et al. Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias. Br J Haematol 2006; 136: 237–248.
Ruggeri L, Capanni M, Mancusi A, Urbani E, Perruccio K, Burchielli E et al. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation. Blood Cells Mol Dis 2004; 33: 216–221.
Uhrberg M, Parham P, Wernet P . Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002; 54: 221–229.
Bottino C, Sivori S, Vitale M, Cantoni C, Falco M, Pende D et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 1996; 26: 1816–1824.
Loughran Jr TP, Hadlock KG, Yang Q, Perzova R, Zambello R, Semenzato G et al. Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes. Blood 1997; 90: 1977–1981.
Pellenz M, Zambello R, Semenzato G, Loughran Jr TP . Detection of Epstein–Barr virus by PCR analyses in lymphoproliferative disease of granular lymphocytes. Leukemia Lymphoma 1996; 23: 371–374.
Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein–Barr viral DNA. J Clin Invest 1989; 84: 51–55.
Zambello R, Semenzato G . Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes. Semin Hematol 2003; 40: 201–212.
Vilches C, Rajalingam R, Uhrberg M, Gardiner CM, Young NT, Parham P . KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. J Immunol 2000; 164: 5797–5804.
Gomez-Lozano N, Gardiner CM, Parham P, Vilches C . Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 2002; 54: 314–319.
Howe EC, Wlodarski M, Ball EJ, Rybicki L, Maciejewski JP . Killer immunoglobulin-like receptor genotype in immune-mediated bone marrow failure syndromes. Exp Hematol 2005; 33: 1357–1362.
Nowakowski GS, Morice WG, Phyliky RL, Li CY, Tefferi A . Human leucocyte antigen class I and killer immunoglobulin-like receptor expression patterns in T-cell large granular lymphocyte leukaemia. Br J Haematol 2005; 128: 490–492.
Doglioni C, Dei Tos A, Barbareschi M . MALT gastric lymphoma: update. Pathologica 1998; 90: 313–317.
Isaacson PG, Diss TC, Wotherspoon AC, Barbazza R, De Boni M, Doglioni C . Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies. Gastroenterology 1999; 117: 750–751.
Acknowledgements
We thank Drs D Senitzer and JY Sun (Duarte, CA, USA) for providing synthetic oligonucleotides for multiplex PCR-SSP, Professor A Moretta for giving mAbs for KIRs cytofluorimetric analysis and the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA, Rome, Italy) who supplied us with epidemiological data about LDGL disease in the Italian population. We are grateful to Dr Martin Donach for editing this paper. This study was supported in part by the Associazione Italiana per la Ricerca sul Cancro (AIRC), the Ministero dell'Istruzione dell'Università e della Ricerca (MIUR) and the Consiglio Nazionale delle Ricerche (CNR), the Fondo per gli Investimenti della Ricerca di Base (FIRB), the Fondo Regionale Regione Veneto, and grants from IOV.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scquizzato, E., Teramo, A., Miorin, M. et al. Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes. Leukemia 21, 1060–1069 (2007). https://doi.org/10.1038/sj.leu.2404634
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404634
Keywords
This article is cited by
-
Large Granular Lymphocytic Leukemia: Current State of Diagnosis, Pathogenesis and Treatment
Current Oncology Reports (2022)
-
KIR repertory in patients with hematopoietic diseases and healthy family members
BMC Hematology (2016)
-
Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies
Cancer Immunology, Immunotherapy (2016)
-
KIR2DL5 alleles mark certain combination of activating KIR genes
Genes & Immunity (2008)